Clinical trials
Phase 3 Sarcoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 7 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Alaunos Therapeutics | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
| Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| ImmunityBio, Inc. | 1 |
| Intensity Therapeutics, Inc. | 1 |
| Mount Sinai Hospital, Canada | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 22 |
| Leiomyosarcoma | 6 |
| Liposarcoma | 6 |
| Histiocytoma, Malignant Fibrous | 5 |
| Rhabdomyosarcoma | 5 |
| Sarcoma, Synovial | 5 |
| Fibrosarcoma | 4 |
| Hemangiosarcoma | 4 |
| Neurofibrosarcoma | 4 |
| Sarcoma, Alveolar Soft Part | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.